1 The Costs of Diabetes in Europe Don’t Lose Sight of the Costs Rhys Williams Prifysgol Cymru Abertawe (University of Wales Swansea, UK)

Slides:



Advertisements
Similar presentations
Core measurements Hanna Tolonen EGHI subgroup on HES, 2 nd March 2011, Luxembourg.
Advertisements

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Presented By: CDR Michael LaPlante PT, DSC, ECS Physical Rehabilitation Director Tuba City Regional Health Care Corporation.
Coronary Heart Disease (CHD): A Disease of Affluence.
Reducing the Risk of Developing Diabetes Chapter 5 Thomas Ransom, Ronald Goldenberg, Amanda Mikalachki, Ally PH Prebtani, Zubin Punthakee Canadian Diabetes.
1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.
Smoking Cessation for Pregnancy and Beyond: Virtual Clinic Companion Slides Catherine A. Powers, EdD, LSW PACE – Tobacco Prevention and Cessation Education.
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
Therapy of Type 2 Diabetes Mellitus: UPDATE
THE NATIONAL HEALTH PRIORITY AREAS Unit 3: Australia’s health / Area of Study 1 Understanding Australia’s Health.
Randomized, double-blind, multicenter, controlled trial.
Frank B. Hu et al N Engl J Med 2004; 351: Body-Mass Index and Relative Risk of Death from All Causes during 24 Years of Follow-up.
Medical Management of obesity Perinatal ANGELS Conference Feb 17, 2005 Philip A. Kern.
Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association Dehko 2D Project (D2D) Implementation Project of the Programme for the Prevention of Type.
Learning Intentions:  Today you will learn about the perceptions of health and how it varies from one person to another. Success Criteria  By the end.
Click to jump back to the Trivia machine Helpful trivia for the Do-It-Yourself health planner Increase your knowledge and plan a healthy life with healthy.
Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes The TODAY clinical trial Featured Article: TODAY Study Group* Diabetes Care Volume.
Modern Management of Cholesterol in the High-Risk Patient.
The findings and conclusions in this presentation are those of the author and do not necessarily represent the views of the CDC. Diabetes Prevention Ann.
ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.
Group 7 Burden of disease in Brazil. KEY HEALTH INDICATORS Years of life lost (YLLs): Years of life lost due to premature mortality. Years lived with.
Diabetes Prevention for a Heterogeneous Population Richard Arakaki, M.D. Professor of Medicine and Chief, Division of Endocrinology and Metabolism John.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Lars Sjöström et al N Engl J Med 2004; 351: Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.
DIABETES STORY LSSI Alum, 2009 Jennifer Muñoz, Del Mar Union School District.
PowerHour Information 03/09/2011.  Background  Description  Vision  Mission  Measurements  Participation Requirements.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Prevention of Diabetes Mellitus Prof. Adel El-Etriby Professor of Cardiology Ain Shams Faculty of Medicine.
A Diabetes Outcome Progression Trial
 GLP-1 agonists have shown to help patients lose weight  Mechanism of GLP-1 agonists  Cardioprotective effects of GLP-1 agonists  GLP-1 agonists and.
 Injuries is one area of the National Health Priority Areas. Injuries include: -Intentional Harm (Suicide) and - Non-Intentional Harm (Falls, poisoning,
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Prevention Of Diabetes. Type 2 Diabetes: Hyperglycemia Insulin Resistance Relative Impairment of Insulin Secretion Pathogenesis: Poorly Understood Genetic.
Diabetes Prevention Program (DPP)
The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. N Engl J Med 2006; available at: End pointActive therapy PlaceboRelative.
Therapy of Type 2 Diabetes Mellitus: UPDATE Glycemic Goals in the Care of Patients with Type 2 Diabetes ADA and AACE Guidelines: Room For Improvement.
Mechanism of Action of Aspirin Carlo Patrono, et al, N Engl J Med 2005;353:
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
What is Obesity? Obesity refers to the presence of excess fat tissue in the body, according to the body mass index (BMI), which is more than 30% body.
Part 3. Diabetes Report Card: HbA 1c Levels in the United States Hoerger TJ, et al. Diabetes Care. 2008;31: Patients (%) HbA 1c (%)
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Medical Consequences of Obesity
Prevention Diabetes.
The cost of diabetes and diabetes care
The SPRINT Research Group
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2017 American Academy of Pediatrics.
PREVALENCE OF HIGH RISK FOR TYPE2 DIABETES IN CENTRAL SPAIN
Prevention Diabetes Dr Abir Youssef 29/11/2018.
Glycemic control for macrovascular disease in type II diabetes: Evidence and insights from recent trials  Sanjay Rajagopalan  Journal of Indian College.
Lifestyle Modification for the Management of Obesity
(p for noninferiority < 0.001)
Masterclass on lifestyle change How to help patients lose weight?
Relative risk reduction for incident hypertension associated with weight loss of 6.8 kg: The Framingham Study Cohort Risk reduction (%) Relative risk.
Enrollment and Outcomes
Effects of Pay-for-Performance on the Quality of Primary Care in England Mean Scores for Clinical Quality at the Practice Level for Aspects of Care for.
Women’s Health Study: Baseline Characteristics Part 1
Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:
Enrollment and Retention
Change in (A) total cholesterol; (B) LDL-cholesterol; (C) HDL-cholesterol and (D) triglycerides over 5 years in response to 12-week intensive lifestyle.
Change in %A1C over 5 years in response to 12-week intensive lifestyle intervention used in a real-world clinical practice. Change in %A1C over 5 years.
Position of the American Dietetic Association: Individual-, Family-, School-, and Community-Based Interventions for Pediatric Overweight    Journal of.
Change in (A) systolic blood pressure and (B) diastolic blood pressure over 5 years in response to 12-week intensive lifestyle intervention in a real-world.
Current insulin dose (units/kg/day) during the DCCT/EDIC study by sex (black line for females) (A), DCCT intensive vs. conventional treatment group (black.
Percentage of weight loss over 5 years in response to 12-week intensive lifestyle intervention in a real-world clinical practice. Percentage of weight.
WASH—World Action on Salt and Health
Presentation transcript:

1 The Costs of Diabetes in Europe Don’t Lose Sight of the Costs Rhys Williams Prifysgol Cymru Abertawe (University of Wales Swansea, UK)

2 The Costs of Diabetes in Europe What are the costs? What can be done about them?

3 What are the costs? Direct costs (of health care) –to society –to the individual and the family Indirect costs (of ‘lost production’) –Sickness absence, premature retirement and premature death Intangible costs –Reduced quality of life - anxiety, pain, discomfort etc.

4

CODE-2 – the Cost of Type 2 Diabetes BEL FRA GER ITA NED SPA SWE UK All countries Direct cost (Billions of Euros )

6 Complications and Hospital Costs 2.1x 3.1x 5.5x

7 What can be done be done about them? People with existing diabetes (type 1 & type 2) –Reducing the risk of complications For people at risk of type 2 diabetes –Primary prevention ‘stopping diabetes before it starts’ These will reduce direct, indirect and intangible costs

8 Intensive therapy is costly to start but less costly in the long run

9 Trials have now shown that physical activity and weight loss reduce risk Source: The N Engl J Med, Volume 346, No 6, page 399

10 Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle Among 522 Overweight Subjects with IGT. The Finnish Diabetes Prevention Study. Weight Change (kg) & Cumulative Incidence of Type 2 Diabetes (%) -3.5 kg -0.8 kg 11% 23% Tuomilehto et al. N. Engl. J. Med (2001). 344, P < intervention control

11 The Costs of Diabetes in Europe Costs are high and getting higher Complications are the most important ‘cost driver’ Costs can be reduced through primary and secondary prevention